clinical trial · NCT07335185
Gravity Stroke System for Recanalization of Large Vessel Occlusion Strokes
Gravity Medical Technology, INC·N/A·not yet recruiting·n = 3,000
StrokeIschemic StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseaseSupernova revascularization device
brief summary
Supernova and Neutron are endovascular mechanical revascularization devices indicated to restore blood flow by removing thrombus from a large intracranial vessel in patients experiencing an acute ischemic stroke within 24 hours of symptom onset or from last known well time.
started
Jan 1, 2026
primary completion
Oct 31, 2030
completion
Dec 31, 2030
last updated
Jan 13, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol